PPM1D is amplified and overexpressed in breast cancers [72,73] and inhibition of its activity, through use of small molecules such as CCT007093, inhibits the growth of tumor cell lines that overexpress PPM1D [74,75]. Here, PPM1D is linked to breast carcinoma.